Questionnaire survey for clinical effectiveness of generic product of hypnotic, zolpidem

Questionnaire survey for clinical effectiveness of generic product of hypnotic, zolpidem - The survey of QOL associated with sleep due to zolpidem

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017264

Enrollment

100

Registered

2015-05-01

Start date

2020-03-31

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Interventions

Oral administration of generic zolpidem. The patients taking zolpidem tartrate tablet continuously or as needed, who were dosed at least seven days to two months ago. Oral administration of branded z

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients taking zolpidem tartrate tablet continuously or as needed, who were dosed at least seven days to two months ago.

Exclusion criteria

Exclusion criteria: The patients with moderate to severe mental diseases such as schizophrenia and depression.

Design outcomes

Primary

Measure	Time frame
The scale of QOL relating to sleep	—

Countries

Japan

Contacts

Public ContactTakayoshi Maiguma

Shujitsu University Faculty of Pharmacy

maiguma@shujitsu.ac.jp086-271-8409

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026